Vesicle Permeabilization by Protofibrillar α-Synuclein:  Implications for the Pathogenesis and Treatment of Parkinson's Disease

581 indexed citations
published 2001

Countries where authors are citing Vesicle Permeabilization by Protofibrillar α-Synuclein:  Implications for the Pathogenesis and Treatment of Parkinson's Disease

Specialization
Citations

This map shows the geographic impact of Vesicle Permeabilization by Protofibrillar α-Synuclein:  Implications for the Pathogenesis and Treatment of Parkinson's Disease. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vesicle Permeabilization by Protofibrillar α-Synuclein:  Implications for the Pathogenesis and Treatment of Parkinson's Disease with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vesicle Permeabilization by Protofibrillar α-Synuclein:  Implications for the Pathogenesis and Treatment of Parkinson's Disease more than expected).

Fields of papers citing Vesicle Permeabilization by Protofibrillar α-Synuclein:  Implications for the Pathogenesis and Treatment of Parkinson's Disease

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Vesicle Permeabilization by Protofibrillar α-Synuclein:  Implications for the Pathogenesis and Treatment of Parkinson's Disease. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Vesicle Permeabilization by Protofibrillar α-Synuclein:  Implications for the Pathogenesis and Treatment of Parkinson's Disease.

About Vesicle Permeabilization by Protofibrillar α-Synuclein:  Implications for the Pathogenesis and Treatment of Parkinson's Disease

This paper, published in 2001, received 581 indexed citations . Written by Michael J. Volles, Seung‐Jae Lee, Jean‐Christophe Rochet, Mark D. Shtilerman, Tomas T. Ding and Peter T. Lansbury covering the research area of Neurology and Physiology. It is primarily cited by scholars working on Neurology (406 citations), Physiology (284 citations) and Molecular Biology (188 citations). Published in Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1021/bi0102398.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026